The French company HPE ingredients (www.hpingredients.com) has launched a new bio-active peptide from snails. In-vitro and in-vivio scientific research of the company has shown a reduction in systolic blood pressure in hypertensive rats with an average decrease of 19-23 mm Hg. The company is also marketing an ‘enzymatic cocktail’ from snails for digestive comfort. HPE Ingrédients is the start-up business, which, from a biotechnological point of view, optimally exploitssnail consumption. It is in fact the first company to offer the health nutrition sector ingredients deriving from snail flesh and other parts of the mollusc.